About HeartSciences
A Healthcare IT company enabling earlier cardiac triage and screening through AI-enabled ECG management, backed by 23+ peer-reviewed publications.
Our Mission
To enable accurate and affordable solutions for the early detection of heart disease.
Cardiovascular disease remains the leading cause of death globally, often because critical conditions go undetected until it's too late. Traditional ECG interpretation misses subtle signs that could enable earlier intervention.
HeartSciences was founded to change that. By combining advanced AI algorithms with clinical-grade ECG acquisition, we're enabling healthcare providers to detect cardiac abnormalities earlier than ever before.
Our technology is the result of years of research, rigorous clinical validation, and collaboration with leading healthcare institutions around the world.
Mission Image
Our Values
Patient First
Everything we do is guided by our commitment to improving patient outcomes.
Scientific Rigor
Our technology is built on a foundation of peer-reviewed clinical research.
Integrity
We maintain the highest standards of ethics in everything we do.
Innovation
We continuously push the boundaries of what AI can achieve in healthcare.
Leadership Team
Our team brings together expertise in AI, cardiology, medical devices, and healthcare innovation.
Andrew Simpson
Chairman & CEO
25+ years medical device experience, led multiple healthcare technology companies.
Mark Hilz
Chief Operating Officer
Operational excellence in scaling healthcare technology companies globally.
Fiona Kathleen Duffy
VP Clinical & Regulatory
Extensive experience in FDA regulatory affairs and clinical trials.
Meeshanthini V. Dogan, PhD
VP Research
Leading AI/ML research in cardiac screening with published work.
Board of Directors
Andrew Simpson
Chairman
Robert Eno
Director
Mark Hilz
Director
David Wells
Director
Yuri Maricich, MD
Director
Scientific Advisors
Leading researchers and clinicians advancing cardiac AI.
Partho P. Sengupta, MD
Ben Glicksberg, PhD
Girish Nadkarni, MD
Jordan Strom, MD
Akhil Vaid, MD
Joshua Lampert, MD
Company Milestones
Company Founded
HeartSciences established with a mission to enable earlier cardiac detection.
First Algorithm
Development of initial AI algorithm for diastolic dysfunction detection.
Clinical Trials
Multi-center clinical validation studies initiated across 12 medical centers.
FDA Clearance
Received 510(k) clearance for MyoVista Insights software.
Commercial Launch
Full commercial availability in the United States.
International Expansion
CE marking obtained, expansion into European markets.
Algorithm Expansion
Enhanced clearance for 12+ cardiac condition detection algorithms.
Ready to Improve Cardiac Detection?
See how 12 validated algorithms can help your clinicians detect cardiac dysfunction earlier. Schedule a 30-minute demo with our clinical team.